COVID-19 in immunocompromised children and adolescents

COVID-19 in immunocompromised children and adolescents

Since coronavirus disease 2019 (COVID-19) became a global pandemic, concerns have arisen regarding the risks of COVID-19 in immunocompromised children and adolescents. Here we aimed to evaluate the clinical outcomes and risks of severe COVID-19 in immunocompromised pediatric patients. Previous studi...

Full description

Bibliographic Details
Main Authors:	Byung Ok Kwak, Byung Wook Eun
Format:	Article
Language:	English
Published:	The Korean Pediatric Society 2023-05-01
Series:	Clinical and Experimental Pediatrics
Subjects:	covid-19 sars-cov-2 immunocompromised child adolescent
Online Access:	http://www.e-cep.org/upload/pdf/cep-2022-00878.pdf

Similar Items

Vaccines and therapeutics for immunocompromised patients with COVID-19
by: Shmuel Shoham, et al.
Published: (2023-05-01)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
by: Mayada Abu Shanap, et al.
Published: (2022-08-01)

Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
by: Daniele Focosi, et al.
Published: (2023-12-01)

A Short Series of Case Reports of COVID-19 in Immunocompromised Patients
by: Mitali Mishra, et al.
Published: (2022-04-01)

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
by: Andrea J. Haddad, et al.
Published: (2024-03-01)

Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19
by: José Aguareles, et al.
Published: (2023-10-01)

Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
by: Mohammad-Mehdi Mehrabi Nejad, et al.
Published: (2022-02-01)

Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
by: Karrie K. K. Ko, et al.
Published: (2022-06-01)

COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital
by: Korbinian Wünsch, et al.
Published: (2022-04-01)

Short-term safety profile of COVID-19 vaccination in children and adolescents with underlying medical conditions: a prospective cohort study
by: Naye Choi, et al.
Published: (2023-06-01)

Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report
by: Melissa Niyonkuru, et al.
Published: (2021-08-01)

Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study
by: Haruka Shimazu, et al.
Published: (2023-11-01)

SARS-CoV-2 infection in a child with Fanconi anemia and determined immunosuppressed status
by: Claudia Chirila, et al.
Published: (2021-09-01)

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
by: Thuan Tong Tan, et al.
Published: (2023-12-01)

Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: Occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients
by: Liang En Wee, et al.
Published: (2022-01-01)

Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery
by: Maamoun Basheer, et al.
Published: (2021-08-01)

Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results
by: Abby Sung, et al.
Published: (2022-02-01)

COVID‐19 in cancer patients: The impact of vaccination on outcomes early in the pandemic
by: Fareed Khawaja, et al.
Published: (2023-12-01)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
by: Hye-Kyung Cho, et al.
Published: (2022-12-01)

The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis
by: Wenting Lu, et al.
Published: (2024-04-01)

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort studyResearch in context
by: Quincy Hofsink, et al.
Published: (2023-07-01)

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
by: Mohammad-Mehdi Mehrabi Nejad, et al.
Published: (2022-08-01)

Treatment of COVID-19 in Patients With Sarcoidosis
by: Shreya Kondle, et al.
Published: (2021-07-01)

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
by: Napaporn Chantasrisawad, et al.
Published: (2022-05-01)

Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture
by: Abeer N. Alshukairi, et al.
Published: (2021-07-01)

Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
by: Astha Thakkar, et al.
Published: (2023-03-01)

Pediatric COVID-19: clinical and epidemiological data of 1303 cases in a general hospital in Brazil
by: Vera Bain, et al.
Published: (2023-12-01)

COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial
by: Chiara Agrati, et al.
Published: (2021-08-01)

Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?
by: Anna Gidari, et al.
Published: (2024-02-01)

Persistent symptoms after COVID-19 in children and adolescents from Argentina
by: Vanesa Seery, et al.
Published: (2023-04-01)

Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
by: Juthaporn Cowan, et al.
Published: (2023-09-01)

SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
by: Johanna Sjöwall, et al.
Published: (2022-06-01)

CLINICAL AND LABORATORY CHARACTERISTICS OF SARS-COV-2 INFECTION IN CHILDREN AND ADOLESCENTS
by: Marlos Melo Martins, et al.
Published: (2020-11-01)

Relapsing COVID-19 infection as a manifestation of Good syndrome: a case report and literature review
by: Liang En Wee, et al.
Published: (2023-04-01)

Case Report: Hyperinflammatory Status in an Immunocompromised Child With a Highly Sustained Viral Load of SARS-CoV-2
by: Matias Moragas, et al.
Published: (2021-08-01)

Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
by: Nina Ekström, et al.
Published: (2024-02-01)

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
by: Eustache Paramithiotis, et al.
Published: (2022-05-01)

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
by: Ivan Gentile, et al.
Published: (2023-12-01)

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review
by: Silvia Martinelli, et al.
Published: (2023-03-01)

Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host
by: Hiroyasu Kaya, et al.
Published: (2023-11-01)